Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes.
Sun D, Sang Z, Kim YJ, Xiang Y, Cohen T, Belford AK, Huet A, Conway JF, Sun J, Taylor DJ, Schneidman-Duhovny D, Zhang C, Huang W, Shi Y.
Sun D, et al. Among authors: sun j.
bioRxiv [Preprint]. 2021 Mar 10:2021.03.09.434592. doi: 10.1101/2021.03.09.434592.
bioRxiv. 2021.
PMID: 33758850
Free PMC article.
Updated.
Preprint.